Hepatitis B

Hepatitis B News

  • HBIG Plus Antivirals May Prevent HBV Reinfection After Transplant A very short course of hepatitis B immunoglobulin (HBIG) after liver transplantation, along with long-term antiviral therapy, may prevent hepatitis B virus (HBV) reinfection, a retrospective study suggests.
  • ILC Nivolumab Improves Sorafenib-Treated Liver Cancer Nivolumab immunotherapy could provide a durable response, and increase survival, for patients with advanced hepatocellular carcinoma who do not respond completely to sorafenib, new research shows.

Hepatitis B Perspective